Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases. [electronic resource]
Producer: 20110512Description: 160-70 p. digitalISSN:- 1536-4844
- Adalimumab
- Adult
- Aged
- Anti-Inflammatory Agents -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Crohn Disease -- drug therapy
- Female
- Flow Cytometry
- Forkhead Transcription Factors -- metabolism
- Humans
- Infliximab
- Male
- Middle Aged
- Prognosis
- Prospective Studies
- T-Lymphocytes, Regulatory -- immunology
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.